Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18053636.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 75-yr-old previously healthy woman presented with gross hematuria, European Cooperative Oncology Group 0, and an 11-cm renal mass with right atrial thrombus. The patient refused the sternotomy. She was offered two cycles of sunitinib maleate (Sutent) induction therapy to down-stage the thrombus and to reduce the extent of the surgery.
Medical subject headings
- Antineoplastic Agents
- Carcinoma, Renal Cell
- Coronary Thrombosis
- Indoles
- Kidney Neoplasms
- Pyrroles